Starboard Wins More Board Seats, Replaces CEO at Depomed

Specialty pharmaceuticals maker Depomed has replaced its chief executive and named two new directors to its board after nearly a year of activist pressure from Starboard Value LP.

from WSJ.com: US Business http://ift.tt/2nswuEr
via IFTTT